Fidelity Disruptive Medicine ETFFMED
Type
ETF
Peer group
Global equity
Net assets
$60.9M
Expense ratio
0.50%
1-year return
+29.5%
3 years, a year
+10.2%
5 years, a year
—
12-month yield
0.00%
Holdings
68
What it aims to do.
Fidelity Disruptive Medicine ETF seeks long-term growth of capital.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| Fidelity Revere Street Trust | 12.56% |
| DHR Danaher Corp | 4.25% |
| Ucb Sa | 4.06% |
| BSX Boston Scientific Corp | 4.04% |
| ARGX Argenx Se | 3.84% |
| COGT Cogent Biosciences Inc | 3.82% |
| ALNY Alnylam Pharmaceuticals Inc | 3.31% |
| ISRG Intuitive Surgical Inc | 3.14% |
| VEEV Veeva Sys Inc | 2.99% |
| PODD Insulet Corp | 2.58% |
More on FMED.
- FMED overview
- FMED holdings
- FMED risk
- FMED costs
- FMED money in and out
- FMED share classes
- Compare FMED with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.